PLUS THERAPEUTICS (PSTV) Stock: Buy, Sell, or Hold?
PSTV - PLUS THERAPEUTICS, Inc. Common Stock
$3.87
0.22 (6.03%)
▲
5d:
+1.04%
30d:
-6.97%
90d:
-36.97%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When PSTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PSTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PSTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PSTV is currently trading at $3.87, which is considered fair based on recent price action.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $3.55, while resistance sits at $4.08. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $36.00 (+830.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $3.55, while resistance sits at $4.08. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $36.00 (+830.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
53/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 830.2% below Wall St target ($36.00)
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
Support & Resistance Levels
Support Level
$3.55
Resistance Level
$4.08
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$36.00
(+830.2%)
Revenue Growth (YoY)
-2.9%
Profit Margin
-230.2%
Share & Embed Analysis
Last updated: October 03, 2026 9:34 AM ET
Data refreshes hourly during market hours. Next update: 10:34 AM
Data refreshes hourly during market hours. Next update: 10:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PSTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
